Are beta-blockers safe and effective after myocardial infarction in patients with COPD?-Reference-Cited by-同舟云学术

Are beta-blockers safe and effective after myocardial infarction in patients with COPD?

Published:2023-03 Issue:3 Volume:36 Page:13-15
ISSN:1547-1896
Container-title:JAAPA
language:en
Short-container-title:

Author:

Davis Lindsay E.,Pogge Elizabeth K.,Garg Rajeev

Abstract

ABSTRACT Clinicians may be hesitant to prescribe beta-blockers in patients with chronic obstructive pulmonary disease (COPD) who have a comorbid compelling cardiovascular indication for beta-blocker therapy. This article summarizes the available data on the safety and efficacy of beta-blockers in patients with COPD and recent myocardial infarction.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Nurse Assisting

Reference20 articles.

1. Beta-blocker underuse in secondary prevention of myocardial infarction;Everly;Ann Pharmacother,2004

2. Defining the relationship between COPD and CVD: what are the implications for clinical practice;Morgan;Ther Adv Respir Dis,2018

3. Beta blockers and chronic obstructive pulmonary disease (COPD): sum of evidence;Baou;Curr Hypertens Rev,2021

4. β -Blockers and the rate of chronic obstructive pulmonary disease exacerbations;Mersfelder;Ann Pharmacother,2019

5. β-Blocker therapy and risk of chronic obstructive pulmonary disease—a Danish nationwide study of 1.3 million individuals;Nielsen;EClinicalMedicine,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays;Handbook of Experimental Pharmacology;2024